Organization - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2020 |
---|---|---|---|
Subsidiary Sale Of Stock [Line Items] | |||
Accumulated deficit | $ (634,135) | $ (574,826) | |
Cash, and investments | $ 373,400 | ||
Underwritten Public Offering | Pre-funded Warrant | |||
Subsidiary Sale Of Stock [Line Items] | |||
Pre-funded warrant, exercise price | $ 0.01 |
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Sum of investments and unrestricted cash as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|